Evidence map›Paper›PMID 35137690›Full record

ArticleeLife2022

Ribonucleotide reductase, a novel drug target for gonorrhea.

Jana Narasimhan, Suzanne Letinski, Stephen P Jung, Aleksey Gerasyuto, Jiashi Wang, Michael Arnold, Guangming Chen, Jean Hedrick, Melissa Dumble, Kanchana Ravichandran and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. A missense mutation in themicroPublication biology · 2023
    Article
  7. Why is manganese so valuable to bacterial pathogens?Frontiers in cellular and infection microbiology · 2023
    Review
  8. The Optimal Management ofMicroorganisms · 2022
    Review
  9. Journal of the American Chemical Society · 2022
    Article
  10. Article
  11. Article
  12. Radicals in Biology: Your Life Is in Their Hands.Journal of the American Chemical Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Jana NarasimhanPTC Therapeutics, Inc, South Plainfield, United States.ORCID https://orcid.org/0000-0001-5621-8592
Suzanne LetinskiPTC Therapeutics, Inc, South Plainfield, United States.
Stephen P JungPTC Therapeutics, Inc, South Plainfield, United States.ORCID https://orcid.org/0000-0002-9276-175X
Aleksey GerasyutoPTC Therapeutics, Inc, South Plainfield, United States.
Jiashi WangPTC Therapeutics, Inc, South Plainfield, United States.
Michael ArnoldPTC Therapeutics, Inc, South Plainfield, United States.
Guangming ChenPTC Therapeutics, Inc, South Plainfield, United States.
Jean HedrickPTC Therapeutics, Inc, South Plainfield, United States.
Melissa DumblePTC Therapeutics, Inc, South Plainfield, United States.
Kanchana RavichandranDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, United States.
Talya LevitzDepartment of Biology, Massachusetts Institute of Technology, Cambridge, United States.
Chang CuiDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, United States.
Catherine L DrennanDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, United States.ORCID https://orcid.org/0000-0001-5486-2755
JoAnne StubbeDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, United States.ORCID https://orcid.org/0000-0001-8076-4489
Gary KarpPTC Therapeutics, Inc, South Plainfield, United States.
Arthur BranstromPTC Therapeutics, Inc, South Plainfield, United States.ORCID https://orcid.org/0000-0002-5917-6372
PTC Therapeutics (United States) · USMassachusetts Institute of Technology · USHarvard University · USHoward Hughes Medical Institute · US

Funding

PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCEST32GM007287 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BELL, STEPHEN P., KEATING, AMY E · 1985 to 2019
$40.8M
Structure-Function Studies of Ribonucleotide ReductaseR01GM047274 · NIGMS · MICHIGAN STATE UNIVERSITY · PI DANIEL G. NOCERA · 1992 to 2026
$9.9M
Ribonucleotide Reductase: Structure and FunctionR01GM029595 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI STUBBE, JOANNE · 1985 to 2016
$6.9M
Metalloenzyme structure, function and assemblyR35GM126982 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CATHERINE L DRENNAN · 2018 to 2026
$3.4M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM029595NIGMS NIH HHS R01 GM047274NIGMS NIH HHS R35 GM126982NIGMS NIH HHS T32 GM007287Wellcome TrustWellcome Trust 097753
6 · The paper itself

Abstract

Antibiotic-resistant

Indexed as

Allosteric RegulationAnimalsAnti-Bacterial AgentsDeoxyadenine NucleotidesDisease Models, AnimalDrug Resistance, BacterialEscherichia coliFemaleGonorrheaHumansMiceMice, Inbred BALB CMicrobial Sensitivity TestsNeisseria gonorrhoeaePyridinesRibonucleotide Reductases2,4-dihydroxypyridine2'-deoxyadenosine triphosphateAnti-Bacterial AgentsDeoxyadenine NucleotidesPyridinesRibonucleotide Reductases2-pyridonegonorrheainfectious diseasemicrobiologymultidrug resistanceneisseria gonorrhoeaeribonucleotide reductase

Identifiers

PMID35137690
PMCPMC8865847
OpenAlexW4210890468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.